Antimicrobial resistance (AMR), a global health concern, poses a significant challenge to present and future medical advancements. AMR occurs when microorganisms like bacteria, viruses, fungi, and parasites develop immunity against antimicrobial drugs, leading to harder-to-treat infections and disease spread. A novel and effective approach to counter AMR involves tapping into behavioral and cultural insights (BCI).
BCI deploys strategies from social and behavioral sciences to understand individual and contextual factors that impact health behaviors, which are germane to the development and implementation of AMR interventions. Standard hospital procedures, social norms among physicians, malpractice fears, antibiotic prescription habits, and diagnostic test availability contribute to AMR-promoting behaviors.
By understanding these behaviors, custom interventions can be created for improved health and behavioral results. Health ministers and representatives from 53 WHO/Europe Member States have given their backing to a new AMR roadmap for the European Region, highlighting BCI as a “high-impact intervention”. WHO/Europe has developed step-by-step tools like the Tailoring Antimicrobial Resistance Programmes (TAP) and Tailoring Health Programmes (THP) to guide health authorities in applying BCI effectively.
Studies conducted by WHO/Europe show the crucial role of health workers’ behaviors in addressing AMR, and pilot projects are being implemented in multiple countries to alter behaviors contributing to AMR. BCI strategies are being utilized in Ukrainian hospitals specifically, due to the rise in resistant infections among war-injury patients and the misuse of antibiotics. BCI is poised as a linchpin in the struggle against AMR, requiring commitment from every stakeholder in the health system.